The COVID-19 viral 3a protein forms a potassium channel that can be inhibited by antiarrhythmic drugs
Author(s) -
Felix Wiedmann,
Emika Boondej,
Megan L. Stanifer,
A Paasche,
Manuel Kraft,
Timon Seeger,
Ulrike Uhrig,
Norbert Frey,
Steeve Boulant,
Constanze Schmidt
Publication year - 2022
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/euac053.604
Subject(s) - medicine , potassium channel , pharmacology , induced pluripotent stem cell , potassium channel blocker , virology , cardiology , microbiology and biotechnology , gene , biology , genetics , embryonic stem cell
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom